Table:
begin	end	state
1	24	cytoplasmic
25	51	transmembrane
52	59	non-cytoplasmic
60	82	transmembrane
83	102	cytoplasmic
103	127	transmembrane
128	153	non-cytoplasmic
154	172	transmembrane
173	183	cytoplasmic
184	203	transmembrane
204	212	non-cytoplasmic
213	234	transmembrane
235	254	cytoplasmic
255	277	transmembrane
278	296	non-cytoplasmic
297	322	transmembrane
323	350	cytoplasmic
351	370	transmembrane
371	376	non-cytoplasmic
377	396	transmembrane
397	407	cytoplasmic
408	427	transmembrane
428	432	non-cytoplasmic
433	451	transmembrane
452	484	cytoplasmic

Input:
>WP_092483642.1 NCBI__GCF_900115975.1:WP_092483642.1
MSVWRKKPVEQVLADKKKNKRGLVPTLGVADLTALGVGAVIGTGIFVLTGVAAANYAGPG
VVFSFILSGIAATLAAMVYAELGAAIPSAGSAYTFSYVSLGEIIAWLVGWNLILEYLVAA
GAVSIGWSSYMGDLLQSVGITLPAAFTSSPFDGGIVNLPAALIVLVITGLIITGTQHSTT
ANKIIVVAKLAAIALFIALGVQHINPANWRPVLPYGISGVFHGAAIVFFAYIGFDAVATA
SEEVKNPQRDLPRGIIWTLVISTLLYIVVAGILTGMVKYTNLNTASPVATALLRAGIPWA
SALVSVGALAGLTSVLLVAMYGQSRIFFAMARDDLLPPIFDWLHPRLRTPVWDSIIIGVL
VALIGAFLPIGLVAELANIGTLTAFIAVSTGAIILRRTNPDLRRPFRLPWMPAIPVLTII
SAGYLAINLPPLTWVRFIAWVAIGLVVYWLYGYRKSKLARESQEVYASRAMPEPARKPED
GKKV

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server